TR199801683A2 - Yeni üre türevleri. - Google Patents

Yeni üre türevleri.

Info

Publication number
TR199801683A2
TR199801683A2 TR1998/01683A TR9801683A TR199801683A2 TR 199801683 A2 TR199801683 A2 TR 199801683A2 TR 1998/01683 A TR1998/01683 A TR 1998/01683A TR 9801683 A TR9801683 A TR 9801683A TR 199801683 A2 TR199801683 A2 TR 199801683A2
Authority
TR
Turkey
Prior art keywords
compounds
new versions
means hydrogen
formula
halogen
Prior art date
Application number
TR1998/01683A
Other languages
English (en)
Other versions
TR199801683A3 (tr
Inventor
Jasserand Daniel
David Samuel
Antel Jochen
Bruckher Reinhard
Eeckhout Christian
Bielenberg Gerhard-Wilhelm
Original Assignee
Solvay Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh filed Critical Solvay Pharmaceuticals Gmbh
Publication of TR199801683A2 publication Critical patent/TR199801683A2/tr
Publication of TR199801683A3 publication Critical patent/TR199801683A3/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Içinde; R1'in hidrojen ya da düsük alkil anlamina, R2'in hidrojen ya da halojen anlamina ve R3'ün hidrojen ya da düsük alkoksi anlamina geldigi formül I'in bilesikleri ve bunlarin fizyolojik olarak uygun asitadisyon tuzlari ve bu bilesikleri içeren ilaçlar ve ayni zamanda bu bilesiklerin elde edilmesine yönelik usul, tarif edilmektedir.Formül (I).
TR1998/01683A 1997-08-27 1998-08-27 Yeni üre türevleri. TR199801683A3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19737274 1997-08-27

Publications (2)

Publication Number Publication Date
TR199801683A2 true TR199801683A2 (tr) 1999-03-22
TR199801683A3 TR199801683A3 (tr) 1999-03-22

Family

ID=7840297

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01683A TR199801683A3 (tr) 1997-08-27 1998-08-27 Yeni üre türevleri.

Country Status (24)

Country Link
US (1) US6001833A (tr)
JP (1) JP4250228B2 (tr)
KR (1) KR19990023605A (tr)
CN (1) CN1108290C (tr)
AR (1) AR015147A1 (tr)
AU (1) AU744104B2 (tr)
BR (1) BR9803237B1 (tr)
CA (1) CA2245484C (tr)
CZ (1) CZ267198A3 (tr)
DE (1) DE19824865A1 (tr)
DZ (1) DZ2597A1 (tr)
HK (1) HK1019604A1 (tr)
HU (1) HUP9801889A1 (tr)
ID (1) ID20787A (tr)
IL (1) IL125885A (tr)
NO (1) NO314939B1 (tr)
NZ (1) NZ331524A (tr)
PL (1) PL193724B1 (tr)
RU (1) RU2198883C2 (tr)
SK (1) SK111098A3 (tr)
TR (1) TR199801683A3 (tr)
TW (1) TW520368B (tr)
UA (1) UA60300C2 (tr)
ZA (1) ZA986721B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10036818A1 (de) 2000-07-28 2002-02-07 Solvay Pharm Gmbh Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
UA75425C2 (en) * 2001-07-09 2006-04-17 Piperazine oxime derivatives with antagonistic activity to nk-1 receptor, use thereof, a pharmaceutical composition based thereon, a method for producing and a method for producing intermediary compounds
ITBO20020198A1 (it) * 2002-04-12 2003-10-13 Univ Bologna Derivati 2 , 5 bis diammino 1 , 4 benzochenionici utili per il trattamento della malattia di alzheimer , metodo per la loro preparazione ed
US20070082905A1 (en) * 2005-05-27 2007-04-12 De Vries Michiel H Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
JP3071829B2 (ja) * 1995-05-25 2000-07-31 藤沢薬品工業株式会社 ニューロキニン受容体拮抗剤としての１−ベンゾイル−２−（インドリル−３−アルキル）−ピペラジン誘導体
GB9519077D0 (en) * 1995-09-18 1995-11-15 Fujisawa Pharmaceutical Co New heterocyclic compounds
FR2744449B1 (fr) * 1996-02-02 1998-04-24 Pf Medicament Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
JP4189043B2 (ja) * 1996-09-30 2008-12-03 株式会社資生堂 Ｎ−アシルピペラジン誘導体及び抗菌剤、抗潰瘍剤

Also Published As

Publication number Publication date
PL193724B1 (pl) 2007-03-30
CA2245484A1 (en) 1999-02-27
CN1108290C (zh) 2003-05-14
KR19990023605A (ko) 1999-03-25
AU744104B2 (en) 2002-02-14
AR015147A1 (es) 2001-04-18
HUP9801889A1 (hu) 2000-11-28
BR9803237A (pt) 2000-02-08
ZA986721B (en) 1999-02-02
SK111098A3 (en) 1999-05-07
HK1019604A1 (en) 2000-02-18
DZ2597A1 (fr) 2003-03-01
CA2245484C (en) 2008-04-29
CZ267198A3 (cs) 1999-03-17
CN1218044A (zh) 1999-06-02
RU2198883C2 (ru) 2003-02-20
NO314939B1 (no) 2003-06-16
TW520368B (en) 2003-02-11
AU8189998A (en) 1999-03-11
JPH11140082A (ja) 1999-05-25
UA60300C2 (uk) 2003-10-15
US6001833A (en) 1999-12-14
TR199801683A3 (tr) 1999-03-22
NO983918D0 (no) 1998-08-26
BR9803237B1 (pt) 2009-05-05
HU9801889D0 (en) 1998-10-28
ID20787A (id) 1999-03-04
DE19824865A1 (de) 1999-03-04
PL328221A1 (en) 1999-03-01
JP4250228B2 (ja) 2009-04-08
IL125885A0 (en) 1999-04-11
NZ331524A (en) 2000-02-28
IL125885A (en) 2000-08-13
NO983918L (no) 1999-03-01

Similar Documents

Publication Publication Date Title
ATE51231T1 (de) Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als antiallergische mittel.
CO4960662A1 (es) Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
ATE323678T1 (de) Tri-aryl-säurederivate als ppar rezeptor liganden
DE69534975D1 (de) Verwendung von noribogain derivaten zur behandlung von chemischer abhängigkeit bei säugern
ATE191473T1 (de) 2,3,5-trimethyl-hydroxyanilid-derivative, ihre herstellung und ihre theraoeutische verwendung
DE69009746T2 (de) Derivate von n-phenylbenzamid mit antiulcerativer sowie antiallergischer aktivität und verfahren zu ihrer herstellung.
HUP0001164A2 (hu) PF1022-ciklodepszipeptid-származékok
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
HUP0204354A2 (hu) Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AU560607B2 (en) Pyridazinones their preparation and use and medicaments containing pyridazinones
ATE234818T1 (de) Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
TR199801683A2 (tr) Yeni üre türevleri.
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
IE780778L (en) 3-pyridazinones.
ATE191465T1 (de) Carbamoylcarbonsäureamide
ATE245986T1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
ATE218138T1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
ES8707939A1 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas
ATE42284T1 (de) Unsymmetrische dihydro-dithiazine, verfahren zu ihrer herstellung und ihre verwendung als riech- und geschmacksstoffe.
AU547599B2 (en) Tricyclic compounds
TW355184B (en) Substituted thiophenylsulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DK231787D0 (da) 3-amino-dihydropyridiner, fremgangsmaade til deres fremstilling og deres anvendelse i laegemidler
ATE17490T1 (de) Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.